Successful Market Access of SaMD & MDSW: Decoding the Confusion in MedTech Software Development
- Avania
- Regulatory Affairs

Software as a medical device (SaMD) is an ever-evolving field, whether it’s the latest updates in risk classification or optimizing your use of the FDA Pre-Cert program for more iterative product development, it is important to know where you stand and what data you need to be successful. Read our white paper to “decode the confusion” in MedTech software development and keep your SaMD project on time and on budget.
Related Reading
Event / Regulatory Affairs
Medical Device Submissions Workshop Series: Investigational Device Exemption (IDE)
8:30 am – 5:15 pm ET
February 5, 2025
Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.
Event / Regulatory Affairs
Medical Device Submissions Series: Premarket Approval (PMA) Workshop
8:30 am – 4:30 pm ET
February 6-7, 2025
Learn key PMA Submissions strategies to build a strong submissions, align with FDA expectations, and reduce delays.
Event / Regulatory Affairs
Medical Device Submissions Series: 510(k) & De Novo Workshop
Now available to purchase!
Join industry leaders for the in-depth 510(k) & De Novo Workshop for real-world case studies, submissions tips and best practices.
News / Government & Legislative Affairs / Health Access / Regulatory Affairs
AdvaMed Urges CMS to Protect Patient Access to Critical Medical Equipment
November 30, 2025
WASHINGTON — AdvaMed, the medtech association, the world’s largest trade association representing medtech innovators, today released the following statement on the U.S. Centers for Medicare & Medicaid Services’ (CMS) release of its 2026 Home Health Prospective Payment System final rule:
Event / Regulatory Affairs
QMSR Transition: Legal and Audit Perspectives
December 9, 2025
11:00 AM – 12:00 PM
Join Hogan Lovells experts to learn how the FDA is set to reshape the medical device regulatory landscape with the introduction of the QMSR.
News / Digital Health / Regulatory Affairs
AdvaMed Releases Technical Performance and Safety Bulletin on “Remote Device Operations: Common Challenges and Mitigation Strategies”
October 2, 2025
WASHINGTON, D.C. – AdvaMed, the Medtech Association, recently published a technical performance and safety bulletin titled, “Remote Device Operations: Common Challenges and Mitigation Strategies” to help health care providers, device manufacturers, and IT teams navigate the complex landscape of remotely managing medical devices.
News / Government & Legislative Affairs / Regulatory Affairs
CDRH Director Tarver, Fellow FDA Leaders to Speak, Take Questions at The MedTech Conference
September 8, 2025
WASHINGTON, D.C.—AdvaMed, the medtech association, today announced a town hall featuring FDA Center for Devices and Radiological Health (CDRH) Director Michelle Tarver and fellow CDRH senior leaders at The MedTech Conference hosted by AdvaMed in San Diego in October. The town hall participants will update the audience on the center’s strategic direction and priorities and take questions.
Blog / Code of Ethics / Compliance / Legal / Regulatory Affairs / The MedTech Conference
AdvaMed in Action: Legal, Compliance, and Regulatory in the Spotlight at The MedTech Conference 2025
August 27, 2025
Christopher L. White, Esq., AdvaMed’s General Counsel & Chief Policy Officer, on why this year’s legal, compliance & regulatory programming is mission-critical as medtech leaders navigate uncertainty, shifting enforcement priorities, and a rapidly changing global legal landscape.